ACTRN12622001371785招募中3 期
Sodium glucose co-transporter 2 inhibitors (SGLT2-I) effect on glucose and sodium clearance in those with stage 4 non-diabetic chronic kidney disease.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Now expanded to Individuals with non-diabetic stage 4 kidney disease with a stable eGFR between 30 and 15 ml/min/1.73m2 for the past 3 months.
- •No change in medications over past 3 months.
- •Not previously on empagliflozin.
排除标准
- •Not able to give informed consent.
研究者
相似试验
进行中（未招募）
1 期
A comparison of two drugs for treating patients with Chronic Kidney Disease and protein in the urineChronic Kidney Disease with albuminuriaMedDRA version: 23.1Level: PTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2022-000740-29-DKDepartment of Renal Medicine, Aarhus University Hospital20
已完成
不适用
The Sodium glucose transporter 2 inhibitor with acute insulin treatment for controlling severe hyperglycemia in patients with type 2 Diabetes mellitustype2 diabetes mellitusJPRN-UMIN000018997Toho University School of Medicine,Divsion of diabetes, metabolism and endocrinology20
招募中
1 期
SOdium-Glucose cotransporter 2 inhibitor, ALDosterone AntagonIst, or both for heart failure with Preserved Ejection Fraction: a two-centre randomised three-treatment three-period crossover trialHeart Failure with Preserved Ejection FractionMedDRA version: 20.1Level: LLTClassification code 10076396Term: Heart failure with preserved ejection fractionSystem Organ Class: 100000004849EUCTR2020-000973-26-PTFaculdade de Medicina da Universidade do Porto108
已完成
不适用
Sodium glucose cotransporter inhibitor 2, Tofogliflozin versus glimepiride, comparative trial in Patients with type 2 diabetes On Body composition (STOP-OB study)Type 2 DiabetesJPRN-UMIN000026161Japan society for Patient Reported Outcome64
已完成
1 期
Effects of sodium glucose co-transporter-2 inhibitor on atrial arrhythmia burden in patient with cardiovascular implantable electronic device: a randomized controlled trialAtrial fibrillation in patients with cardiac implantable electronic deviceTCTR20210315003Faculty of Medicine, Chiang Mai University166